Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs propofol sedation (Japan, Phase 3)
jRCT2080225057Phase 3Completed
- Start
- Feb 2020
- Modality
- Small Molecules
01
Overview
Phase 3 trial of dexmedetomidine in Sedation requirement and anxiety disorder (2 arms). Started Feb 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Sedation requirementanxiety disorder
Beyond the preview
Go deeper on jRCT2080225057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225057.